Literature DB >> 11553984

In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy.

H Shinotoh1, H Namba, M Yamaguchi, K Fukushi, S Nagatsuka, M Iyo, M Asahina, T Hattori, S Tanada, T Irie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11553984

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  4 in total

1.  Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.

Authors:  B Ravina; M Putt; A Siderowf; J T Farrar; M Gillespie; A Crawley; H H Fernandez; M M Trieschmann; S Reichwein; T Simuni
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

Review 2.  Transdermal treatment options for neurological disorders: impact on the elderly.

Authors:  Lorenzo Priano; Maria Rosa Gasco; Alessandro Mauro
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 3.  [Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors].

Authors:  I Liepelt; W Maetzler; H-P Blaicher; T Gasser; D Berg
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

4.  Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.

Authors:  Yilin Tang; Jingjie Ge; Fengtao Liu; Ping Wu; Sisi Guo; Zhenyang Liu; Yixuan Wang; Ying Wang; Zhengtong Ding; Jianjun Wu; Chuantao Zuo; Jian Wang
Journal:  PLoS One       Date:  2016-04-11       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.